Pharma/Fine Chemicals Roundup – September 4

HOSPIRA TO ACQUIRE API FACILITY IN INDIA FOR $200 MILLION Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an agreement to acquire an active pharmaceutical ingredient (API) manufacturing facility and an associated R&D facility from Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, for about $200 million. The API manufacturing facility is located at Aurangabad, India, and it employs about 640 people; the associated R&D facility is...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers